INFINITI CYP2C19 Assay regulatory update

FDA granted 510(k) clearance for AutoGenomics' INFINITI CYP2C19 Assay as an aid to clinicians in determining a therapeutic strategy for drugs that are metabolized by the CYP450 2C19 gene. The in vitro...